Related Experiment Video
Updated: Aug 10, 2026

06:12
Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
Published on: March 17, 2023
1.9K
Biosensing extracellular vesicles: contribution of biomolecules in affinity-based methods for detection and isolation
M Gaillard1, A Thuaire, G Nonglaton
1Univ. Grenoble Alpes, CEA, CNRS, IRIG, SyMMES, 38000 Grenoble, France. camille.raillon@cea.fr yoann.roupioz@cea.fr.
The Analyst
|January 22, 2020
Summary
Extracellular vesicles (EVs) are key for cell communication and disease detection. This review explores novel DNA aptamers and peptides as stable ligands for biosensors to isolate and detect EVs, advancing biomarker discovery.
Area of Science:
- Biotechnology
- Biochemistry
- Nanotechnology
Background:
- Extracellular vesicles (EVs) mediate intercellular communication and are promising disease biomarkers.
- EVs possess surface proteins crucial for their isolation and detection via biochemical methods.
- Current isolation techniques face challenges with protein stability, necessitating alternative ligand strategies.
Purpose of the Study:
- To review biomolecules used as ligands in affinity-based biosensors for EV detection and isolation.
- To highlight the advantages of emerging non-denaturable biomolecules like DNA aptamers and peptides.
- To discuss the application of these ligands in various biosensor platforms for EV analysis.
Main Methods:
- Review of literature on affinity-based biosensors for EV detection.
- Analysis of biomolecules (antibodies, DNA aptamers, peptides) as ligands for EV isolation.
- Examination of biosensor types (electrochemical, optical, microfluidic) utilizing these ligands.
- Discussion of generic and specific probes for EV targeting.
Main Results:
- DNA aptamers offer superior stability, ease of production, and high affinity compared to antibodies.
- Peptides provide a complementary biochemical approach for targeting EV membrane proteins.
- Biosensors employ diverse ligands, including generic probes (e.g., tetraspanins) and specific probes (e.g., cancer biomarkers).
Conclusions:
- DNA aptamers and peptides represent advanced, stable alternatives to antibodies for EV detection and isolation.
- Biosensor technology utilizing these novel ligands enhances the potential of EVs as diagnostic biomarkers.
- The development of versatile biosensors is crucial for advancing EV-based diagnostics and therapeutics.

